Fundraising Fox
/Companies
Sign in

Encapsulate

Founded 2019 · 16 employees on LinkedIn · 3 known investors

Find your way into Encapsulate

Sign up to see every warm intro you have to Encapsulate

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Encapsulate team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Encapsulate builds automated tumor-on-a-chip systems that test microtumors derived from patient biopsies against treatment regimens to predict how individual cancer patients will respond, delivering personalized insights in under seven days. It serves oncologists, pharmaceutical companies, and cancer researchers, drawing on a patient biobank for drug testing, patient stratification, and mechanism studies.

BiotechHealthtechMedical Devices

Founders & leadership

Encapsulate was founded in 2019 by Armin Rad and Leila Daneshmandi.

ARArmin Rad
Armin RadCo-founder & CEOArmin Rad holds a PhD in Biomedical Engineering and has worked on encapsulation technologies, targeted drug delivery, tissue engineering, and medical device development before co-founding Encapsulate, which develops tumor-on-a-chip systems for personalized cancer treatment prediction.
LDLeila Daneshmandi
Leila DaneshmandiCo-founder & COOLeila Daneshmandi holds a Ph.D. in Biomedical Engineering and a Master's in Global Entrepreneurship from the University of Connecticut, where she serves as an Assistant Professor in Innovation and Entrepreneurship and founding director of the Entrepreneurship Hub. She is co-founder and COO of Encapsulate, a medical technology company developing automated tumor-on-a-chip systems for personalized cancer treatment.
BSBret Schipper
Bret SchipperCMO
JS
John StrahleyCFO

Investors · 3

Connecticut Innovations✓ confirmed by EncapsulateNew Haven · $500K – $2M

How we know: Connecticut Innovations's portfolio page · the company's own site · Not right? Tell us

Blackwood Healthcare BreakthroughsreportedCoto De Caza

How we know: a partner's Signal profile · Not right? Tell us

Related companies · 1

BioworldBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.

Companies working in the same space as Encapsulate.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Science FoundationPhase I2022$256K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

Frequently asked questions

What does Encapsulate do?
Encapsulate builds automated tumor-on-a-chip systems that test microtumors derived from patient biopsies against treatment regimens to predict how individual cancer patients will respond, delivering personalized insights in under seven days. It serves oncologists, pharmaceutical companies, and cancer researchers, drawing on a patient biobank for drug testing, patient stratification, and mechanism studies.
Who founded Encapsulate?
Encapsulate was founded by Armin Rad, Leila Daneshmandi in 2019.
Who are Encapsulate's investors?
Encapsulate's investors include Ambit Health Ventures, Connecticut Innovations, Blackwood Healthcare Breakthroughs.